Literature DB >> 6703950

Computed tomographic findings in Wernicke-Korsakoff syndrome.

J R McDowell, H J LeBlanc.   

Abstract

An unconscious patient had a differential diagnosis of coma. Traumatic, metabolic, and infectious origins were considered, but none explained her condition satisfactorily. Clinical features on examination were compatible with Wernicke-Korsakoff syndrome. Her condition improved with supportive treatment and thiamine hydrochloride administration. A computed tomographic scan showed large, symmetric, low-density thalamic lesions, the condition of which improved after three months.

Entities:  

Mesh:

Year:  1984        PMID: 6703950     DOI: 10.1001/archneur.1984.04050160119026

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

Review 1.  The blood-brain barrier and selective vulnerability in experimental thiamine-deficiency encephalopathy in the mouse.

Authors:  N Harata; Y Iwasaki
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 2.  Mechanisms of neuronal cell death in Wernicke's encephalopathy.

Authors:  A S Hazell; K G Todd; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

3.  Computed tomography and magnetic resonance imaging in a young patient with Wernicke's encephalopathy.

Authors:  T Kitaguchi; T Kobayashi; S Tobimatsu; I Goto; Y Kuroiwa
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

4.  Computed tomography findings in thiamine deficiency-induced coma.

Authors:  Andrea J Swenson; Erik K St Louis
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 5.  Neuronal cell death in Wernicke's encephalopathy: pathophysiologic mechanisms and implications for PET imaging.

Authors:  D K Leong; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 6.  Neuroimaging of the Wernicke-Korsakoff syndrome.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Alcohol Alcohol       Date:  2008-12-09       Impact factor: 2.826

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.